# Untreated HIV-1 infection and low CD4+ T cell counts and their effect on endemic human coronavirus (re)infection

**Authors:** Ferdyansyah Sechan, Anne W. M. van den Hurk, T. Sonia Boender, Maria Prins, Amy Matser, Margreet Bakker, Neeltje A. Kootstra, Lia van der Hoek

PMC · DOI: 10.1371/journal.pgph.0004610 · PLOS Global Public Health · 2025-06-18

## TL;DR

This study found that people with untreated HIV-1 are not at higher risk of reinfection with common human coronaviruses compared to those without HIV.

## Contribution

The study provides new insights into the effect of untreated HIV-1 and CD4+ T cell counts on human coronavirus reinfection risk.

## Key findings

- PLWH not on cART had significantly lower antibody levels for all HCoVs compared to PWoH.
- There was no significant difference in HCoV infection incidence rate between PLWH and PWoH.
- HCoV infection incidence rate was not affected by immune deficiency in PLWH.

## Abstract

People living with HIV-1 (PLWH) treated with combination antiretroviral therapy (cART) have similar incidence of SARS-CoV-2 infection compared to people without HIV-1 (PWoH). Yet, roughly 25% PLWH worldwide are currently not accessing cART. The influence of CD4+ T cell depletion on human coronavirus (HCoV) (re)infection risk, including SARS-CoV-2, is largely unknown. In this research, we investigated the incidence of infection by the four endemic HCoVs (HCoV-NL63, HCoV-229E, HCoV-OC43, and HCoV-HKU1), to inform on future reinfections by SARS-CoV-2. We compared the HCoV infection incidence rate between PLWH (n = 24) and PWoH (n = 25) who were followed up in 1984–1993; i.e., before cART became generally available in high income countries. Both populations were followed up at 6-month intervals for 7 or 8 years. We also compared the HCoV infection incidence rate among PLWH with and without immune deficiency, defined as CD4+ T cell count < 350 cell/mm3 and > 350 cell/mm3 respectively. We found that the antibody levels for all HCoVs were significantly lower in PLWH than PWoH across all timepoints. However, we observed no significant difference on HCoV infection incidence rate between PLWH and PWoH. We also observed no difference in HCoV infection incidence rate among PLWH with and without immune deficiency. We conclude that PLWH not on cART may not be at increased risk of HCoV reinfections.

## Linked entities

- **Diseases:** SARS-CoV-2 (MONDO:0100096)

## Full-text entities

- **Genes:** CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}
- **Diseases:** SARS-CoV-2 infection (MESH:D000086382), immune deficiency (MESH:D007154), HIV-1 infection (MESH:D015658), infection (MESH:D007239)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676], Human coronavirus HKU1 (no rank) [taxon 290028], Orthocoronavirinae (subfamily) [taxon 2501931], Human coronavirus OC43 (no rank) [taxon 31631], Human coronavirus 229E (no rank) [taxon 11137], Human coronavirus NL63 (no rank) [taxon 277944], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12176178/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12176178/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12176178/full.md

---
Source: https://tomesphere.com/paper/PMC12176178